But patients are at the heart of the GLP-1 trend, and the Obesity Action Coalition is there to provide support, education and advocacy for those who want to use these medications as part of their weight-loss plan
Because hunger is such a powerful motivator of behaviour, it often causes failure when weight loss is attempted through behavioural modification alone
Clinicians treating obesity should screen for the presence of eating disorder psychopathology before prescribing GLP-1RAs, as these medications are contraindicated in cases of overweight or obesity associated with atypical anorexia nervosa, bulimia nervosa, and subthreshold bulimia nervosa
Financial Performance 8.5.3.3
With over two weeks still to go, we have a special opportunity to go beyond the basics and scale the impact of this project
After an overnight fast, a single tablet in the empty stomach allows SNAC to briefly raise local pH, shield semaglutide from proteolysis, and drive highly localized transcellular uptake directly across the gastric mucosa